Despite “breast is best” campaigns and rising breastfeeding rates, the $20.5 billion global infant formula market is here to stay, with approximately 78 million infants utilizing infant formula in 2014 alone. As science advances and researchers deepen their understanding of the complexity of mother's milk, developers of infant formula strive to mimic human breast milk as closely as possible. However, we now know infant formula falls short, as the majority of formulas lack probiotics – live microorganisms thought to have crucial functions in the optimal development of infants that are present in natural mother's milk. This report forecasts the adoption of probiotics in the infant formula market in the coming decade.
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)